QA: Insys Therapeutics Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516479_2015_Insys_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001516479, Insys Therapeutics Inc

  xvar xval
0 AssetsCurrent 151,042,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 29,872,000
3 remainder_Assets 34,207,000
4 LiabilitiesCurrent 45,676,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 3,778,000
7 CostOfGoodsAndServicesSold 22,578,000
8 SellingGeneralAndAdministrativeExpense 44,283,000
9 ResearchAndDevelopmentExpense 33,136,000
10 remainder_Expenses 84,304,000
11 remainder_Revenues 222,125,000
12 remainder_NetIncome 153,000
13 remainder_ComprehensiveNetIncome -24,000
  yvar yval
0 Assets 215,121,000
1 Liabilities 49,454,000
2 Expenses 184,301,000
3 Revenues 222,125,000
4 StockholdersEquity 165,667,000
5 NetIncome 37,977,000
6 ComprehensiveNetIncome 37,965,000
7 BaseVar 335,589,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.02
9 EconomicCapitalRatio 3.70

Edgar->Model Mapping

Feature Distribution

Change over Time